Previously, we ran a special on Surge Holdings Inc (OTCQB:SURG) focusing on some of the technical factors, as well as fundamentals that have got under the radar for most of 2019. From that report, when SURG was at $0.305 per share, we have updated Surge Holdings to a “BUY Status […]
China Targeting US Cannabis Companies for Mergers and Acquisitions; Who are the likely Targets?
As products made with CBD, or cannabidiol, take off in the U.S., Chinese business men and women are looking cash in. Recently, China has lifted some restrictions on its industry, signalling a significant push into the market in the USA and Canada. Recently the WSJ visited China’s cannabis heartland and how […]
New Merger Utilizing “Fusion Triangle” Opens the Door to Possibly Biggest merger to Hit US OTC markets in last 5 years.
Previously, we have outlined how a new system for Chinese businesses to enter the US and Canadian markets amid highly restrictive trans-border regulations, coining the term “Fusion Triangle”. The idea is that Chinese companies and individuals would purchase non-active shell companies that are already publicly listed on a lower-tier stock […]
Significant Growth Expected Following Recent Acquisition for Surge Holdings (SURG); Upgraded to BUY Status.
We are bullish on Surge Holdings Inc. (OCTQB:SURG) as a small-cap growth opportunity in the high growth Fintech space. From a technical standpoint, we have updated Surge Holdings to a “BUY Status, 97%”, with support holding for the last 10 trading days, with moving average lines now converging. Most significant: Today […]
Who are the Main Players in the Growing Investment Trend in Psychedelic Medicine?
A new trend is emerging in the wake of the Cannabis craze of recent years, that of Psychedelic medicine and the investment opportunities it might bring with new legalization. Recently, a new report was released showing that psilocybin-assisted talk therapy was an effective treatment for addictions such as alcohol and […]
Famed CEO responsible for Taking StemTech to over $50 Million takes over Small-Cap company StemSation Interational (STSN)
Hard hitting CEO Ray Carter Jr., who was responsible for growing the company StemTech to $65 million, has announced he is now the CEO of StemSation International Inc (OTC:STSN). For over 30 years, Ray has directed growth in both private and public direct selling companies, from start-ups to Fortune 500 […]
Cannabis Stocks Witness Record High Trading Volume, With No Sign of Letting up.
Cannabis stocks got off to a slow start in 2020, with many company missing projections, and even more cannabis start ups being forced to close up shop. The “Big 3” Cannabis companies continued to show strength, however their rate of increase has slowed in recent months. However, today investors were […]
Exclusive with Matt Dwyer, CEO of Global Consortium Inc (OTCpink:GCGX)
Highlights: Previous Interview talking about their new Cannabis Mall via SmallCapVoice.com Thanks for having us Matt. How is 2020 treating the company so far? Busy, this is the first year going back as far as I can remember not having any down time over the holidays. Last quarter of 2019 was […]
Exclusive with Matthew Moore, CEO of InnerScope Hearing Technologies Inc (OTCQB:INND).
We are very happy to have you here Mr. Moore, thank you. How is 2020 treating you and your company so far? Thank you for having me, and being able to talk about InnerScope Hearing Technologies. 2020 has started off very well for InnerScope. A lot of Business Development opportunities […]
Chinese Businessman on a Mission to bring credibility to a Stock Exchange Abhorred by Wall Street Investors with a “Fusion Triangle”.
It’s rare that a campaign backed by the Chinese government fails to secure the funding and assets needed to expand, particularly into the USA. This is due mainly to the fact that China, and its regulators, have put significant barriers in place to curb a possible collapse or significant negative […]